SCHEMBL541399

SCHEMBL541399

CCCCCCCCCCCCCC(=O)Nc1ccccc1

nearest known ligand 0.96

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
SOAT2 O75908 1/20 0.82
SOAT1 P35610 1/20 0.82
HDAC1 Q13547 11/20 0.72
HDAC3 O15379 11/20 0.72
HDAC2 Q92769 10/20 0.72
ICMT O60725 1/20 0.72
ALB P02768 1/20 0.72
HDAC8 Q9BY41 13/20 0.72
HDAC6 Q9UBN7 11/20 0.72
HDAC4 P56524 9/20 0.72
HDAC7 Q8WUI4 9/20 0.72
HDAC11 Q96DB2 9/20 0.72
HDAC9 Q9UKV0 9/20 0.72
HDAC5 Q9UQL6 9/20 0.72
HDAC10 Q969S8 8/20 0.72
KDM4E B2RXH2 1/20 0.72
BRD4 O60885 1/20 0.72
NCOR1 O75376 1/20 0.72
NR1I2 O75469 1/20 0.72
EGFR P00533 1/20 0.72

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8743007 1.00 SOAT2 (0.82) SOAT2SOAT1HDAC1HDAC3HDAC2
SCHEMBL8743085 1.00 SOAT2 (0.82) SOAT2SOAT1HDAC1HDAC3HDAC2
SCHEMBL9388173 1.00 SOAT2 (0.82) SOAT2SOAT1HDAC1HDAC3HDAC2
SCHEMBL2138777 1.00 SOAT2 (0.82) SOAT2SOAT1HDAC1HDAC3HDAC2
SCHEMBL8743011 1.00 SOAT2 (0.82) SOAT2SOAT1HDAC1HDAC3HDAC2
SCHEMBL282938 1.00 SOAT2 (0.82) SOAT2SOAT1HDAC1HDAC3HDAC2
SCHEMBL8743155 1.00 SOAT2 (0.82) SOAT2SOAT1HDAC1HDAC3HDAC2
SCHEMBL8742971 1.00 SOAT2 (0.82) SOAT2SOAT1HDAC1HDAC3HDAC2
SCHEMBL8743258 1.00 SOAT2 (0.82) SOAT2SOAT1HDAC1HDAC3HDAC2
Hexadecanoic Acid Phenylamide SCHEMBL4138725 1.00 SOAT2 (0.82) SOAT2SOAT1HDAC1HDAC3HDAC2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 15 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20260062580-A1 REVERSIBLY THERMOCHROMIC COMPOSITION, REVERSIBLY THERMOCHROMIC MICROCAPSULE PIGMENT ENCAPSULATING REVERSIBLY THERMOCHROMIC COMPOSITION, AND WRITING INSTRUMENT USING REVERSIBLY THERMOCHROMIC MICROCAPSULE PIGMENT THE PILOT INK CO., LTD. (JP) 2026-03-05 US disclosed
US-12460099-B2 Reversibly thermochromic composition, reversibly thermochromic microcapsule pigment encapsulating reversibly thermochromic composition, and writing instrument using reversibly thermochromic microcapsule pigment THE PILOT INK CO., LTD. (JP) 2025-11-04 US disclosed
WO-2025080981-A1 TEMPERATURE INDICATION LABELS MICROTEK LABORATORIES, INC. (US) 2025-04-17 WO disclosed
US-20250123158-A1 TEMPERATURE INDICATION LABELS MICROTEK LABORATORIES, INC. (US) 2025-04-17 US disclosed
EP-3608386-B1 REVERSIBLY THERMOCHROMIC COMPOSITION, AND REVERSIBLY THERMOCHROMIC MICROCAPSULE PIGMENT HAVING SAME ENCLOSED THEREIN PILOT INK CO LTD (JP) 2025-02-19 EP disclosed
US-12123107-B2 Reversibly thermochromic composite fiber KABUSHIKI KAISHA PILOT CORPORATION (JP) 2024-10-22 US disclosed
US-20230018132-A1 REVERSIBLY THERMOCHROMIC AQUEOUS INKJET PRINTER INK COMPOSITION, INKJET PRINTER AND INK CARTRIDGE USING THE SAME RISO TECHNOLOGIES CORPORATION (JP) 2023-01-19 US disclosed
US-20220169919-A1 REVERSIBLY THERMOCHROMIC COMPOSITION, REVERSIBLY THERMOCHROMIC MICROCAPSULE PIGMENT ENCAPSULATING REVERSIBLY THERMOCHROMIC COMPOSITION, AND WRITING INSTRUMENT USING REVERSIBLY THERMOCHROMIC MICROCAPSULE PIGMENT THE PILOT INK CO., LTD. (JP) 2022-06-02 US disclosed
EP-3950068-A1 REVERSIBLE THERMOCHROMIC COMPOSITION, REVERSIBLE THERMOCHROMIC MICROCAPSULE PIGMENT COMPRISING SAME, AND WRITING INSTRUMENT USING SAME THE PILOT INK CO., LTD. (JP) 2022-02-09 EP disclosed
US-8188282-B2 Regioselective palladium catalyzed synthesis of benzimidazoles and azabenzimidazoles SANOFI-AVENTIS (FR) 2012-05-29 US disclosed
EP-2044033-B1 A REGIOSELECTIVE PALLADIUM CATALYZED SYNTHESIS OF BENZIMIDAZOLES AND AZABENZIMIDAZOLES SANOFI SA (FR) 2012-02-08 EP disclosed
US-20090203912-A1 Regioselective palladium catalyzed synthesis of benzimidazoles and azabenzimidazoles SANOFI-AVENTIS (FR) 2009-08-13 US disclosed
EP-2044033-A1 A REGIOSELECTIVE PALLADIUM CATALYZED SYNTHESIS OF BENZIMIDAZOLES AND AZABENZIMIDAZOLES Sanofi-Aventis (FR) 2009-04-08 EP disclosed
WO-2008009348-A1 A REGIOSELECTIVE PALLADIUM CATALYZED SYNTHESIS OF BENZIMIDAZOLES AND AZABENZIMIDAZOLES SANOFI-AVENTIS (FR) 2008-01-24 WO disclosed
EP-1878724-A1 A regioselective palladium catalyzed synthesis of benzimidazoles and azabenzimidazoles sanofi-aventis (FR) 2008-01-16 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20260062580-A1 REVERSIBLY THERMOCHROMIC COMPOSITION, REVERSIBLY THERMOCHROMIC MICROCAPSULE PIGMENT ENCAPSULATING REVERSIBLY THERMOCHROMIC COMPOSITION, AND WRITING INSTRUMENT USING REVERSIBLY THERMOCHROMIC MICROCAPSULE PIGMENT TYR, SCO2, HBB SOAT2 2022/4885SOAT1 2226/4885HDAC1 4615/4885
US-20090203912-A1 Regioselective palladium catalyzed synthesis of benzimidazoles and azabenzimidazoles DDT, NIT2, PADI1 SOAT2 3501/4885SOAT1 3948/4885HDAC1 586/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.